微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 7.34% | 10.04% | 53.24% | 27/132 | 0.36% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.79% | 14.32% | 102.97% | 25/132 | 1.85% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.36% | -5.22% | -72.43% | 37/132 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 8.56% | -11.39% | 28.34% | 38/132 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 6.67% | -16.94% | 59.19% | 46/132 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.19% | -25.04% | 68.27% | 46/132 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.49% | -33.6% | -74.22% | 40/132 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.66% | -28.6% | 20.3% | 33/132 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.03% | -30.78% | 43.65% | 42/132 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.59% | -30.13% | 49.07% | 38/132 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.75% | 11.61% | -72.28% | 29/132 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 13.53% | -3.15% | 16.64% | 46/132 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 11.6% | 1.75% | 45% | 48/132 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 8% | 27.39% | 138.1% | 43/132 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.36% | 31.76% | -75.95% | 46/132 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 13.97% | 25.63% | 22.54% | 61/132 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 11.4% | 25.97% | 81.53% | 51/132 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.28% | 22.42% | 146.27% | 67/132 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.55% | 31.44% | -77.07% | 59/132 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 11.12% | 18.05% | 22.87% | 83/132 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 9.05% | 9.17% | 76.41% | 54/132 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 5.13% | 1.99% | 164.43% | 70/132 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.94% | -13.78% | -79.41% | 42/132 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 9.42% | -9.77% | 13.63% | 79/132 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 8.29% | -6.96% | 64.81% | 38/132 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.03% | 4.36% | 123.56% | 45/132 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.25% | 14.21% | -78.45% | 29/132 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 10.44% | 14.98% | 17.17% | 67/132 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 8.91% | 15.71% | 84.85% | 30/132 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.82% | 12.62% | 144.67% | 29/132 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 1.97% | -5.29% | -78.3% | 31/132 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 9.08% | -32.44% | 17.92% | 68/132 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 7.7% | -28.1% | 79.91% | 28/132 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.28% | -31.85% | 105.77% | 36/132 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.08% | 2% | -84.52% | 23/132 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 13.44% | 3.78% | 25.49% | 42/132 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 10.71% | 2% | 70.54% | 14/132 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 6.28% | 2.45% | -51.51% | 20/132 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2015-12-31 | 12.95% | 37.77% | 111.26% | 33/132 | 15.95% | 健帆生物 | 7.75% | 行业排名> |
| 2015-06-30 | 6.13% | 2% | -34.79% | 22/132 | 7.77% | 大博医疗 | 55.39% | 行业排名> |